Ke Cao

757 total citations
11 papers, 577 citations indexed

About

Ke Cao is a scholar working on Molecular Biology, Cancer Research and Materials Chemistry. According to data from OpenAlex, Ke Cao has authored 11 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Cancer Research and 1 paper in Materials Chemistry. Recurrent topics in Ke Cao's work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (9 papers) and Circular RNAs in diseases (7 papers). Ke Cao is often cited by papers focused on MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (9 papers) and Circular RNAs in diseases (7 papers). Ke Cao collaborates with scholars based in China, Russia and United States. Ke Cao's co-authors include Kiyoshi Yanagisawa, Yasushi Matsuyama, Ayumu Taguchi, Takashi Takahashi, Hidemi Goto, Masaharu Tanaka, Peiguo Cao, Xiang Chen, Jianda Zhou and Jianda Zhou and has published in prestigious journals such as Cancer Research, Oncotarget and Journal of Cellular and Molecular Medicine.

In The Last Decade

Ke Cao

11 papers receiving 568 citations

Peers

Ke Cao
Comparison fields: 5 of 67
  • Cancer Research 465
  • Molecular Biology 448
  • Oncology 54
  • Immunology 44
  • Pulmonary and Respiratory Medicine 35
Replace Shun‐Quan Wu with:
Shun‐Quan Wu China
Feng-Wei Wang China
Kei Ihira Japan
Luxi Qian China
Xun Zhu China
Masahisa Ishibashi Japan
Chengcheng Ren China
Xiao-Han Jin China
Markéta Bednaříková Czechia
Yichao Wang China
Shun‐Quan Wu China View profile →
Citations per field, relative to Ke Cao
Ke Cao · 1×
Citations per year, relative to Ke Cao
Ke Cao · 1×

Countries citing papers authored by Ke Cao

Since Specialization
Citations

This map shows the geographic impact of Ke Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Cao more than expected).

Fields of papers citing papers by Ke Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Cao. The network helps show where Ke Cao may publish in the future.

Co-authorship network of co-authors of Ke Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Cao. A scholar is included among the top collaborators of Ke Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Cao. Ke Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
# Work Indexed citations
1 12
2 39
3 20
4 31
5 35
6 21
7 86
8 36
9
MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo.
27
10
miR-199a-5p regulates the expression of metastasis-associated genes in B16F10 melanoma cells.
28
11 242

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026